Re: Looking forward now , can/will management use this meeting as the start of many positive updates?
|
3
|
Resverlogix Corp.
|
Aug 31, 2022 12:03PM
|
Re: Looking forward now , can/will management use this meeting as the start of many positive updates?
|
3
|
Resverlogix Corp.
|
Aug 30, 2022 12:56PM
|
Re: Resverlogix Publishes New Data Highlighting Apabetalone’s Benefit in Non-alcoholic Fatty Liver Disease
|
4
|
Resverlogix Corp.
|
Aug 23, 2022 05:21PM
|
Re: Covid
|
1
|
Resverlogix Corp.
|
Aug 14, 2022 09:20PM
|
Re: Covid
|
7
|
Resverlogix Corp.
|
Aug 12, 2022 01:06PM
|
Re: Thrown in the towel?
|
5
|
Resverlogix Corp.
|
Aug 04, 2022 11:52AM
|
Re: Bank value of your shares
|
1
|
Zenith Epigenetics
|
Aug 01, 2022 02:52PM
|
Re: HOW LONG
|
5
|
Resverlogix Corp.
|
Jul 27, 2022 11:02AM
|
Re: ZHCLF
|
5
|
Zenith Epigenetics
|
Jul 25, 2022 02:29PM
|
Re: ZHCLF
|
2
|
Zenith Epigenetics
|
Jul 22, 2022 04:35PM
|
Re: ZHCLF
|
1
|
Zenith Epigenetics
|
Jul 21, 2022 12:43PM
|
Re: Gilead's GS-5829 flops in mCRPC
|
3
|
Zenith Epigenetics
|
Jul 20, 2022 09:26AM
|
Re: Gilead's GS-5829 flops in mCRPC
|
2
|
Zenith Epigenetics
|
Jul 19, 2022 04:42PM
|
Re: Zenith Epigenetics Announces Initiation of a Phase 2b Triple Negative Breast Cancer (TNBC) Clinical Trial
|
1
|
Zenith Epigenetics
|
Jun 28, 2022 07:42PM
|
Re: Question re BOD votes
|
3
|
Resverlogix Corp.
|
Jun 27, 2022 02:18PM
|
Re: More insider buying
|
4
|
Resverlogix Corp.
|
Jun 27, 2022 01:15PM
|
Re: Question re BOD votes
|
4
|
Resverlogix Corp.
|
Jun 27, 2022 11:45AM
|
Re: More insider buying
|
2
|
Resverlogix Corp.
|
Jun 27, 2022 11:05AM
|
Re: Where are the Questions ?
|
4
|
Resverlogix Corp.
|
Jun 21, 2022 07:32PM
|
Re: LINK for the AGM
|
2
|
Resverlogix Corp.
|
Jun 21, 2022 07:24PM
|